102 related articles for article (PubMed ID: 6157610)
1. Antithrombin III activity and other coagulation changes in proliferative diabetic retinopathy.
Elder GE; Mayne EE; Daly JG; Kennedy AL; Hadden DR; Montgomery DA; Weaver JA
Haemostasis; 1980; 9(5):288-96. PubMed ID: 6157610
[TBL] [Abstract][Full Text] [Related]
2. Plasma haemostatic factors and diabetic retinopathy.
Dornan TL; Rhymes IL; Cederholm-Williams SA; Rizza CR; Pepys MB; Bron AJ; Turner RC
Eur J Clin Invest; 1983 Jun; 13(3):231-5. PubMed ID: 6191995
[TBL] [Abstract][Full Text] [Related]
3. Platelet and coagulation factors in proliferative diabetic retinopathy.
Borsey DQ; Prowse CV; Gray RS; Dawes J; James K; Elton RA; Clarke BF
J Clin Pathol; 1984 Jun; 37(6):659-64. PubMed ID: 6202721
[TBL] [Abstract][Full Text] [Related]
4. Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy.
Christe M; Fritschi J; Lämmle B; Tran TH; Marbet GA; Berger W; Duckert F
Thromb Haemost; 1984 Oct; 52(2):138-43. PubMed ID: 6084321
[TBL] [Abstract][Full Text] [Related]
5. Plasma fibronectin, factor VIII-related antigen and fibrinogen concentrations, and diabetic retinopathy.
Davis TM; Moore JC; Turner RC
Diabete Metab; 1985 Jun; 11(3):147-51. PubMed ID: 3928410
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolysis and diabetic retinopathy.
Almér LA; Pandolfi M
Diabetes; 1976; 25(2 SUPPL):807-10. PubMed ID: 61139
[TBL] [Abstract][Full Text] [Related]
7. Diabetic retinopathy and the fibrinolytic system.
Almér LO; Pandolfi M; Nilsson IM
Diabetes; 1975 Jun; 24(6):529-34. PubMed ID: 49282
[TBL] [Abstract][Full Text] [Related]
8. Coagulation factors of contact phase of haemostasis are normal in well-controlled type-I diabetic patients despite presence of diabetic retinopathy.
Watzke H; Schernthaner G; Schnack C; Schwarz HP; Prskavec F; Freyler H
Diabetes Res; 1988 Apr; 7(4):197-200. PubMed ID: 3402169
[TBL] [Abstract][Full Text] [Related]
9. [Glycosylated proteins and various hemostatic indices in diabetic retinopathy].
Genova V; Petrunova N; Kamenov V; Baleva M; Nikolov K
Vutr Boles; 1987; 26(3):60-4. PubMed ID: 2441529
[TBL] [Abstract][Full Text] [Related]
10. The relationship of soluble immune complexes, insulin antibodies and insulin-anti-insulin complexes to platelet and coagulation factors in type 1 diabetic patients with and without proliferative retinopathy.
Di Mario U; Borsey DQ; Contreas G; Prowse CV; Clarke BF; Andreani D
Clin Exp Immunol; 1986 Jul; 65(1):57-65. PubMed ID: 2947762
[TBL] [Abstract][Full Text] [Related]
11. The metabolism of fibrinogen and plasminogen related to diabetic retinopathy in man.
Cederholm-Williams SA; Dornan TL; Turner RC
Eur J Clin Invest; 1981 Apr; 11(2 Suppl 1):133-8. PubMed ID: 6785097
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of blood viscosity in diabetic retinopathy.
Peduzzi M; Melli M; Fonda S; Codeluppi L; Guerrieri F
Int Ophthalmol; 1984 Jan; 7(1):15-9. PubMed ID: 6706469
[TBL] [Abstract][Full Text] [Related]
13. [Alpha 2-macroglobulin in the blood of patients with diabetes mellitus].
Turecký L; Kupcová V; Szántová M
Bratisl Lek Listy; 1999 Jan; 100(1):25-7. PubMed ID: 10492994
[TBL] [Abstract][Full Text] [Related]
14. Thrombin inhibitors in women on oral contraceptives.
Guagnellini E; Bertolini G; Cappelletti M; Colombo G
Acta Haematol; 1981; 65(3):205-10. PubMed ID: 6165217
[TBL] [Abstract][Full Text] [Related]
15. [The level of factor VIII/von Willebrand and inhibitors in diabetic retinopathy].
Petrunova N; Genova V; Baleva M; Nikolov K
Vutr Boles; 1988; 27(5):46-50. PubMed ID: 2463712
[TBL] [Abstract][Full Text] [Related]
16. Plasma fibrinopeptide A, beta-thromboglobulin, and platelet factor 4 in diabetic retinopathy.
Roy MS; Podgor MJ; Rick ME
Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):856-60. PubMed ID: 2967258
[TBL] [Abstract][Full Text] [Related]
17. [Changes of antithrombin (antithrombin III, alpha2-macroglobulin) in various diseases (author's transl)].
Matsuda T; Ogawara M; Kodama N; Murakami M
Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):261-6. PubMed ID: 70147
[No Abstract] [Full Text] [Related]
18. In-vitro venous prostacyclin production, plasma 6-keto-prostaglandin F1 alpha concentrations, and diabetic retinopathy.
Davis TM; Bown E; Finch DR; Mitchell MD; Turner RC
Br Med J (Clin Res Ed); 1981 Apr; 282(6272):1259-62. PubMed ID: 6784805
[TBL] [Abstract][Full Text] [Related]
19. Increased thromboplastic potential in diabetes: a multifactorial phenomenon.
Landgraf-Leurs MM; Ladik T; Smolka B; Bock T; Schramm W; Spannagl M; Landgraf R
Klin Wochenschr; 1987 Jul; 65(13):600-6. PubMed ID: 3626428
[TBL] [Abstract][Full Text] [Related]
20. Role of altered coagulation-fibrinolytic system in the pathophysiology of diabetic retinopathy.
Behl T; Velpandian T; Kotwani A
Vascul Pharmacol; 2017 May; 92():1-5. PubMed ID: 28366840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
